Along with blood sugar control, Ozempic has shown to promote weight loss primarily due to its impact on appetite and gastric ...

Judges allow consolidation of vision loss lawsuits filed against Novo Nordisk and Eli Lilly over diabetes and weight loss ...

Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.

As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them ...

A wave of transformative US drug-pricing agreements and record manufacturing investments from leading biopharmaceutical ...

Shares have corrected 55.8 per cent from their high earlier this year of $423.32 to $187.01 based on the Dec. 11 closing ...

Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...

Find insight on Corcept Therapeutics, vaccine skepticism and more in the latest Market Talks covering the health care sector.

GLP-1 weight loss drugs are proving beneficial for people struggling with obesity and diabetes, but there is another surprising side effect coming to light.

BME’s portfolio is a who’s-who of medical-device makers. What’s more, Becton Dickinson is not a top-10 holding (it’s No. 16, ...